StoneX Group’s Zhengye Biotechnology Holding ZYBT Stock Holding History

StoneX Group’s Portfolio ZYBT Stock Details ZYBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.6K	Buy	+17,661	New	+$27.1K	﹤0.01%	1710

Other funds holding ZYBT

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's ZYBT Position: Q3 2026 in Review

StoneX Group opened a new position in Zhengye Biotechnology Holding (ZYBT) in Q3 2026: 17,661 shares worth $25.6K. The stake represents ﹤0.01% of the portfolio and ranks #1710 among its holdings.

2 funds tracked by Wall St. Rank hold ZYBT as of Q3 2026.

StoneX Group held 17,661 shares of Zhengye Biotechnology Holding worth $25.6K as of Q3 2026.
Zhengye Biotechnology Holding was a new StoneX Group position in Q3 2026.
Zhengye Biotechnology Holding made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1710 holding.
2 funds tracked by Wall St. Rank held Zhengye Biotechnology Holding as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.